The WACC of Eagle Pharmaceuticals Inc (EGRX) is 7.7%.
| Range | Selected | |
| Cost of equity | 10.10% - 13.20% | 11.65% |
| Tax rate | 39.20% - 44.10% | 41.65% |
| Cost of debt | 4.70% - 5.40% | 5.05% |
| WACC | 6.8% - 8.6% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.35 | 1.48 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.10% | 13.20% |
| Tax rate | 39.20% | 44.10% |
| Debt/Equity ratio | 0.82 | 0.82 |
| Cost of debt | 4.70% | 5.40% |
| After-tax WACC | 6.8% | 8.6% |
| Selected WACC | 7.7% | |